ArticleFrontiers in genetics2022

FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy.

Jiehua Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.